Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes

OBJECTIVE: Because of the short potential doubling time of esophageal cancer, there is a theoretical benefit to using an accelerated radiation treatment schedule. This study evaluates outcomes and treatment-related mortality and morbidity of patients treated with neoadjuvant hyperfractionated accele...

Descripción completa

Detalles Bibliográficos
Autores principales: Samuels, Stuart E., Stenmark, Matthew H., Lee, Jae Y., McHugh, Jonathan B., Hayman, James A., Orringer, Mark B., Urba, Susan G., Sun, Libin, Xie, Congying, Kong, Feng-Ming, Cuneo, Kyle C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605317/
https://www.ncbi.nlm.nih.gov/pubmed/29114597
http://dx.doi.org/10.1016/j.adro.2017.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605317/
https://www.ncbi.nlm.nih.gov/pubmed/29114597
http://dx.doi.org/10.1016/j.adro.2017.05.003

Ejemplares similares